Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

115 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pertuzumab and trastuzumab: the rationale way to synergy.
Richard S, Selle F, Lotz JP, Khalil A, Gligorov J, Soares DG. Richard S, et al. Among authors: selle f. An Acad Bras Cienc. 2016;88 Suppl 1:565-77. doi: 10.1590/0001-3765201620150178. An Acad Bras Cienc. 2016. PMID: 27275646 Free article. Review.
Optimal Treatment Duration of Bevacizumab as Front-Line Therapy for Advanced Ovarian Cancer: AGO-OVAR 17 BOOST/GINECO OV118/ENGOT Ov-15 Open-Label Randomized Phase III Trial.
Pfisterer J, Joly F, Kristensen G, Rau J, Mahner S, Pautier P, El-Balat A, Kurtz JE, Canzler U, Sehouli J, Heubner ML, Hartkopf AD, Baumann K, Hasenburg A, Hanker LC, Belau A, Schmalfeldt B, Denschlag D, Park-Simon TW, Selle F, Jackisch C, Burges A, Lück HJ, Emons G, Meier W, Gropp-Meier M, Schröder W, de Gregorio N, Hilpert F, Harter P. Pfisterer J, et al. Among authors: selle f. J Clin Oncol. 2023 Feb 1;41(4):893-902. doi: 10.1200/JCO.22.01010. Epub 2022 Nov 4. J Clin Oncol. 2023. PMID: 36332161 Clinical Trial.
Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial.
Oaknin A, Gladieff L, Martínez-García J, Villacampa G, Takekuma M, De Giorgi U, Lindemann K, Woelber L, Colombo N, Duska L, Leary A, Godoy-Ortiz A, Nishio S, Angelergues A, Rubio MJ, Fariñas-Madrid L, Yamaguchi S, Lorusso D, Ray-Coquard I, Manso L, Joly F, Alarcón J, Follana P, Romero I, Lebreton C, Pérez-Fidalgo JA, Yunokawa M, Dahlstrand H, D'Hondt V, Randall LM; ENGOT-Cx10–GEICO 68-C–JGOG1084–GOG-3030 Investigators. Oaknin A, et al. Lancet. 2024 Jan 6;403(10421):31-43. doi: 10.1016/S0140-6736(23)02405-4. Epub 2023 Dec 1. Lancet. 2024. PMID: 38048793 Clinical Trial.
[Dose density and dose intensity in the treatment of breast cancer].
Saintigny P, Assouad S, Gligorov J, Selle F, Roché H, Breau JL, Morère JF, Lotz JP. Saintigny P, et al. Among authors: selle f. Bull Cancer. 2004 Dec 1;91 Suppl 4:S244-53. Bull Cancer. 2004. PMID: 15899616 Free article. Review. French.
[Updates on gemcitabine on metastatic breast cancer].
Gligorov J, Selle F, Khalil A, Abbas F, Namer M, Lotz JP. Gligorov J, et al. Among authors: selle f. Bull Cancer. 2007;94 Spec No Actualites:S90-4. Bull Cancer. 2007. PMID: 17845977 Review. French.
[Chemotherapy in the elderly: how and for whom?].
Avenin D, Selle F, Gligorov J, Japkowicz M, Houssel P, Carette B, Bernard M, Abbas F, Khalil A, Bourayou N, Lokiec F, Carola E, Saint-Jean O, Leblond V, Bouvard E, Lotz JP. Avenin D, et al. Among authors: selle f. Bull Cancer. 2008 May 28;95 FMC Onco:F28-36. doi: 10.1684/bdc.2007.0537. Bull Cancer. 2008. PMID: 18511364 French.
[Chemotherapy-induced cardiotoxicity in the elderly].
Bernard M, Avenin D, Selle F, Gligorov J, Houssel P, Carette B, Bourayou N, Lokiec F, Carola E, Lotz JP. Bernard M, et al. Among authors: selle f. Bull Cancer. 2008 May 28;95 FMC Onco:F89-95. doi: 10.1684/bdc.2007.0533. Bull Cancer. 2008. PMID: 18511374 French.
Influence of ABCB1 polymorphisms and docetaxel pharmacokinetics on pathological response to neoadjuvant chemotherapy in breast cancer patients.
Lévy P, Gligorov J, Antoine M, Rezai K, Lévy E, Selle F, Saintigny P, Lokiec F, Avenin D, Beerblock K, Lotz JP, Bernaudin JF, Fajac A. Lévy P, et al. Among authors: selle f. Breast Cancer Res Treat. 2013 Jun;139(2):421-8. doi: 10.1007/s10549-013-2545-7. Epub 2013 May 11. Breast Cancer Res Treat. 2013. PMID: 23666532
115 results